Rigel Pharmaceuticals
RIGL
RIGL
163 hedge funds and large institutions have $401M invested in Rigel Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 50 increasing their positions, 56 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.19% less ownership
Funds ownership: 8.07% → 7.88% (-0.19%)
11% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 56
Holders
163
Holding in Top 10
1
Calls
$1.35M
Puts
$750K
Top Buyers
| 1 | +$7.63M | |
| 2 | +$5.4M | |
| 3 | +$5.08M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$2.46M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$2.25M |
Top Sellers
| 1 | -$6.12M | |
| 2 | -$3.74M | |
| 3 | -$3.46M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.11M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.99M |